Illumina completes offering of 4 million shares
NEW YORK --Genetic analysis company Illumina Inc. said Wednesday it completed its public offering of about 4 million common shares, raising net proceeds of about $342.6 million.
The underwriter of the offering fully exercised its option to purchase up to 525,000 additional shares.
Shares were sold at $87.50.
Goldman, Sachs & Co. acted as the sole manager of the offering.
Shares fell 54 cents to $89.83 in morning trading. 